NCT06517056 Emovi 3D Knee Assessment Device Intervention for Operational Readiness
| NCT ID | NCT06517056 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Womack Army Medical Center |
| Condition | Patellofemoral Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-10-24 |
| Primary Completion | 2025-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2024-10-24 with a primary completion date of 2025-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomized clinical trial investigating the use of the Emovi Knee Kinesiography information in the treatment of anterior knee pain in physical therapy.
Eligibility Criteria
Inclusion Criteria: * Age 18-50 * Active Duty Service Member stationed at Fort Liberty and Schofield Barracks * Diagnosis of patellofemoral pain (ICD-10 codes: M25.2 (pain in unspecified knee), M25.561 (pain in right knee), and M25.562 (pain in left knee) Exclusion Criteria: * Pregnancy * Known to be leaving that duty station within next 3 months * Concurrent lower limb injuries (examples include but are not limited to ankle sprain or HS strain) * Previous knee surgery * History of traumatic knee injury, such as a ligament tear or meniscal tear * Presence of rheumatoid or neurological disease
Contact & Investigator
Don L Goss, DPT, PhD
PRINCIPAL INVESTIGATOR
Womack Army Medical Center
Frequently Asked Questions
Who can join the NCT06517056 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Patellofemoral Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06517056 currently recruiting?
Yes, NCT06517056 is actively recruiting participants. Contact the research team at dgoss@highpoint.edu for enrollment information.
Where is the NCT06517056 trial being conducted?
This trial is being conducted at Honolulu, United States, Fort Liberty, United States.
Who is sponsoring the NCT06517056 clinical trial?
NCT06517056 is sponsored by Womack Army Medical Center. The principal investigator is Don L Goss, DPT, PhD at Womack Army Medical Center. The trial plans to enroll 180 participants.